Equity Overview
Price & Market Data
Price: $5.49
Daily Change: -$0.21 / 3.83%
Daily Range: $5.41 - $5.80
Market Cap: $13,947,443
Daily Volume: 39,451
Performance Metrics
1 Week: -6.47%
1 Month: -29.16%
3 Months: -44.09%
6 Months: -21.57%
1 Year: -88.38%
YTD: -45.79%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.